Loading...
Beta Drugs Limited — Lapatinib Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #7 for Lapatinib · $17.3K export value · DGFT Verified
Beta Drugs Limited is the #7 Indian exporter of Lapatinib with $17.3K in export value and 14 verified shipments. Beta Drugs Limited holds a 0.3% market share in Lapatinib exports across 2 countries. The company exports 17 pharmaceutical products worth $7.8M across 5 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.1M | 23 | 50.3% |
| UNITED ARAB EMIRATES | $450.0K | 9 | 19.7% |
| KAZAKHSTAN | $169.5K | 5 | 7.4% |
| PHILIPPINES | $120.7K | 7 | 5.3% |
| VENEZUELA | $65.5K | 17 | 2.9% |
| PERU | $50.0K | 1 | 2.2% |
| EGYPT | $47.7K | 1 | 2.1% |
| CONGO | $42.9K | 1 | 1.9% |
| KENYA | $41.0K | 50 | 1.8% |
| TURKEY | $37.2K | 18 | 1.6% |
India exports Lapatinib to 49 countries. The top destination is UNITED STATES (50.3%), followed by UNITED ARAB EMIRATES and KAZAKHSTAN.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMINCORP | PHILIPPINES | $119.5K | 5 |
| M/S. UPS | UNITED STATES | $100.0K | 2 |
| TOROPH | KAZAKHSTAN | $99.4K | 3 |
| TOROPH , | KAZAKHSTAN | $70.1K | 2 |
| THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS | TURKEY | $24.7K | 2 |
| NUEVOS ETICOS NEOETHICALS S A | GUATEMALA | $12.3K | 3 |
India exported $1.9M worth of Lapatinib through 300 shipments from 86 suppliers to 49 countries, serving 128 buyers globally. Beta Drugs Limited contributes $17.3K to this total, accounting for 0.3% of India's Lapatinib exports.
Beta Drugs Limited's average Lapatinib shipment value is $1.2K per consignment, based on 14 shipments totaling $17.3K.
Beta Drugs Limited ranks #7 among 86 Indian Lapatinib exporters with a 0.3% market share. The top 3 exporters are NATCO PHARMA LIMITED ($1.1M), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($600.0K), MEDWISE OVERSEAS PRIVATE LIMITED ($47.2K). Beta Drugs Limited processed 14 shipments to 2 destination countries.
What Beta Drugs Limited must comply with to export Lapatinib to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | IKRIS PHARMA NETWORK PRIVATE LIMITED | $20.0K | 3 | 1 | $6.7K |
| 6 | SHREE KRISHNA LIFECARE | $18.5K | 7 | 1 | $2.6K |
| 7 | BETA DRUGS LIMITED ★ | $17.3K | 14 | 2 | $1.2K |
| 8 | CAPLIN POINT LABORATORIES LIMITED | $17.1K | 5 | 2 | $3.4K |
| 9 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 83 | 27.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 72 | 24.0% |
| DELHI AIR | 27 | 9.0% |
| DELHI AIR CARGO ACC (INDEL4) | 22 | 7.3% |
| Bombay Air | 13 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 11 | 3.7% |
| CHENNAI AIR | 10 | 3.3% |
| HYDERABAD AIR | 7 | 2.3% |
Beta Drugs Limited also exports these advanced oncology products. Each links to the detailed product page.
Beta Drugs Limited exports 17 products worth $7.8M. Beyond Lapatinib, top products include Linagliptin, Sitagliptin, Carboplatin, Capecitabine, Mercaptopurine. View the complete Beta Drugs Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Lapatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Beta Drugs Limited's Lapatinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Beta Drugs Limited
Full Company Profile →
17 products · $7.8M total trade · 5 categories
| JAMAICA |
| $10.6K |
| 3 |
India's Lapatinib is purchased by 128 buyers worldwide. The top buyer is AMINCORP (PHILIPPINES), followed by M/S. UPS and TOROPH.
| HEET HEALTHCARE PRIVATE LIMITED |
| $11.8K |
| 4 |
| 3 |
| $2.9K |
Beta Drugs Limited ranks #7 among 86 Indian Lapatinib exporters. Average shipment value of $1.2K compared to the market average of $21.6K. The closest competitors by value are IKRIS PHARMA NETWORK PRIVATE LIMITED and SHREE KRISHNA LIFECARE.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 49+ countries, 128+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Beta Drugs Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lapatinib. For current shipment-level data, contact TransData Nexus.